All Industries

Top Drug Discovery Companies

234 Drug Discovery companies, sorted by total funding raised.

BiomX

Clinical‑stage company developing natural and engineered bacteriophage cocktails and personalized...

Ness Ziona, Israel51–200Biotech, Drug Discovery
Series B·$56.0M·Feb 2019
Appia BioClosed

Develops allogeneic CAR‑iNKT cell therapies from hematopoietic stem cells to treat cancers, partn...

Los Angeles, United States11–50Biotech, Drug Discovery
Series A·$52.0M·May 2021
Rubedo Life Sciences

Clinical-stage biopharma developing therapies that target senescent/pathologic cells to treat age...

Sunnyvale, United States11–50Biotech, Drug Discovery
Series A·$52.0M·Apr 2024
Manas AI

AI-native biopharmaceutical company using neuro-symbolic models to accelerate drug discovery for ...

New York, United States1–10Life Sciences, Artificial Intelligence
Extension Round·$50.6M·Sep 2025
Virobay

Antiviral drug discovery and development company focused on treatments for autoimmune diseases, n...

Menlo Park, United States1–10Biotech, Drug Discovery
Series B·$48.0M·Jul 2014
Tata 1mgAcquired

Indian online pharmacy and healthcare platform offering medicines, lab tests, doctor consultation...

Gurgaon, India1001–5000E-Commerce, Healthcare
Series D·$46.8M·Sep 2022
Peptone

Biotechnology company designing small-molecule therapeutics that target intrinsically disordered ...

London, United Kingdom11–50Artificial Intelligence, Biotech
Series A·$42.5M·Jun 2022
Hydra Biosciences, Inc.Closed

Private biopharmaceuticals company pioneering the discovery of novel drugs using its expertise in...

Cambridge, United States11–50Biotech, Drug Discovery
Series D·$40.9M·Jan 2009
Arpeggio Bio

Arpeggio Bio develops drugs targeting transcription factors using AI…

Boulder, United States11–50Biotech, Drug Discovery
Series B·$40.2M·Nov 2025
Manifold Bio

Platform therapeutics company building an AI-guided in vivo drug discovery engine for tissue-targ...

Cambridge, United States1–10Biotech, Drug Discovery
Series A·$40.0M·Jul 2022
Shiru

Shiru leverages ML to create proteins to feed the world sustainably.

Emeryville, United States1–10Agtech, Artificial Intelligence
Series B·$36.6M·Nov 2024
ReceptosClosed

Biopharmaceutical company that developed immune-inflammatory therapies, notably ozanimod (RPC-106...

San Diego, United States51–200Biotech, Drug Discovery
Venture Unknown·$35.8M·Mar 2012
Permanence Bio

Developing therapeutics to stop mutations to prevent cancer

San Francisco, United States1–10Biotech, Drug Discovery
Series A·$35.0M·Jan 2026
Transcode Therapeutics, Inc.

R&D company with 3 SBIR/STTR awards from Department of Health and Human Services.

Boston, United States1–10Biotech, Drug Discovery
Series B·$33.0M·Oct 2025
Sorriso Pharmaceuticals

Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying anti...

Sandy, United States1–10biotech, pharmaceuticals
Series A·$31.0M·Dec 2021
Form Bio

AI-driven platform for designing and optimizing genetic medicines and genome engineering for biot...

Austin, United States11–50Artificial Intelligence, Biotech
Series A·$30.0M·Sep 2022
Great Bay Bio 大湾生物

By utilizing AI and other cutting-edge technologies, GBB aims to address the challenges of long t...

San Francisco Bay Area, China51–200Artificial Intelligence, Biotech
Series B·$28.8M·Dec 2024
Scioto BiosciencesAcquired

Scioto is a preclinical stage company developing innovative therapies devoted to having a transfo...

Indianapolis, United States1–10Food & Beverage, Biotech
Series B·$28.3M·Aug 2020
TwoStep Therapeutics

A versatile integrin-binding peptide, PIP

San Carlos, United States1–10Biotech, Drug Discovery
Series A·$27.6M·Jan 2026
Envisagenics

AI-driven biotechnology company discovering RNA splicing targets and developing therapeutics for ...

Long Island City, United States11–50Artificial Intelligence, Biotech
Series B·$27.4M·Jun 2024
Adimab

Provides antibody discovery and engineering services to biopharma partners using a yeast-based pl...

Lebanon, United States51–200Antibody Discovery, Biopharmaceutical
Series F·$26.0M·Jan 2012
Converge Bio

Generative AI platform for accelerated drug discovery and molecule design serving pharma and biot...

Tel Aviv, Israel11–50Artificial Intelligence, Biotech
Series A·$25.0M·Jan 2025
PostEra

Medicinal Chemistry powered by Machine Learning

Boston, United States11–50Drug Discovery, Healthcare
Series A·$24.0M·Jan 2022
1910 Genetics

Make undruggable targets a thing of the past

Mountain View, United States11–50Drug Discovery, Healthcare
Series A·$22.0M·Mar 2021
Talus Bio

Discovering drugs that target the DNA regulome

Seattle, United States11–50Biotech, Drug Discovery
Venture Unknown·$21.7M·Aug 2024